165 related articles for article (PubMed ID: 25281835)
1. Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes.
Herbert KJ; Holloway A; Cook AL; Chin SP; Snow ET
Toxicol Appl Pharmacol; 2014 Nov; 281(1):136-45. PubMed ID: 25281835
[TBL] [Abstract][Full Text] [Related]
2. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
3. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
[TBL] [Abstract][Full Text] [Related]
4. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
6. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
Tabuchi T; Satoh M; Itoh T; Nakamura M
Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66
Costantino S; Paneni F; Mitchell K; Mohammed SA; Hussain S; Gkolfos C; Berrino L; Volpe M; Schwarzwald C; Lüscher TF; Cosentino F
Int J Cardiol; 2018 Oct; 268():179-186. PubMed ID: 30047409
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated miR-34a-SIRT1-acetyl p65 axis is a potential mediator of immune activation in the colon during chronic simian immunodeficiency virus infection of rhesus macaques.
Mohan M; Kumar V; Lackner AA; Alvarez X
J Immunol; 2015 Jan; 194(1):291-306. PubMed ID: 25452565
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1.
Li N; Muthusamy S; Liang R; Sarojini H; Wang E
Mech Ageing Dev; 2011 Mar; 132(3):75-85. PubMed ID: 21216258
[TBL] [Abstract][Full Text] [Related]
12. Decreased levels and activity of Sirt1 are modulated by increased miR-34a expression in adipose tissue mononuclear cells from subjects with overweight and obesity: A pilot study.
Briones-Espinoza MJ; Cortés-García JD; Vega-Cárdenas M; Uresti-Rivera EU; Gómez-Otero A; López-López N; Mejía-Torres M; Portales-Pérez DP
Diabetes Metab Syndr; 2020; 14(5):1347-1354. PubMed ID: 32755834
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
Hu N; Long H; Zhao M; Yin H; Lu Q
Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
[TBL] [Abstract][Full Text] [Related]
14. MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.
Zhang HS; Chen XY; Wu TC; Sang WW; Ruan Z
FEBS Lett; 2012 Nov; 586(23):4203-7. PubMed ID: 23103739
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
16. Long-term arsenic exposure induces histone H3 Lys9 dimethylation without altering DNA methylation in the promoter region of p16(INK4a) and down-regulates its expression in the liver of mice.
Suzuki T; Nohara K
J Appl Toxicol; 2013 Sep; 33(9):951-8. PubMed ID: 22733434
[TBL] [Abstract][Full Text] [Related]
17. Upregulated sirtuin 1 by miRNA-34a is required for smooth muscle cell differentiation from pluripotent stem cells.
Yu X; Zhang L; Wen G; Zhao H; Luong LA; Chen Q; Huang Y; Zhu J; Ye S; Xu Q; Wang W; Xiao Q
Cell Death Differ; 2015 Jul; 22(7):1170-80. PubMed ID: 25526086
[TBL] [Abstract][Full Text] [Related]
18. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
19. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of DNA methylation induced by past arsenic treatment causes persistent genomic instability in mammalian cells.
Mauro M; Caradonna F; Klein CB
Environ Mol Mutagen; 2016 Mar; 57(2):137-50. PubMed ID: 26581878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
